We are looking for:
- Type 2 Diabetes patients who inject medication
- NASH patients who inject medication
We are looking to speak to people who have been diagnosed with Type 2 Diabetes or NASH (a form of non-alcoholic fatty liver disease) and currently use an injectable medication, to take part in a research study in March.
The aim of the study is to test the usability and concept of a novel technology (which includes a voice and text chatbot application) that would support an injectable device.
1-1 usability test sessions will last 60 minutes and you will receive a reimbursement of £65.